110 related articles for article (PubMed ID: 3125056)
1. Dynamic phosphorus-31 NMR study of sugar cataract and its prevention in rat lenses with aldose reductase inhibitors.
Thomas DM; Mahendroo PP; Lou MF
Exp Eye Res; 1988 Jan; 46(1):37-47. PubMed ID: 3125056
[TBL] [Abstract][Full Text] [Related]
2. The effect of an aldose reductase inhibitor on lens phosphorylcholine under hyperglycemic conditions: biochemical and NMR studies.
Lou MF; Garadi R; Thomas DM; Mahendroo PP; York BM; Jernigan HM
Exp Eye Res; 1989 Jan; 48(1):11-24. PubMed ID: 2493385
[TBL] [Abstract][Full Text] [Related]
3. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats.
Griffin BW; McNatt LG; Chandler ML; York BM
Metabolism; 1987 May; 36(5):486-90. PubMed ID: 3106757
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
Lou MF; Xu GT; Zigler S; York B
Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
[TBL] [Abstract][Full Text] [Related]
5. Effect of an aldose reductase inhibitor, AL-1576, on the development of UV-B and X-ray cataract.
Schmitt C; Schmidt J; Wegener A; Hockwin O
Graefes Arch Clin Exp Ophthalmol; 1988; 226(5):455-60. PubMed ID: 3142804
[TBL] [Abstract][Full Text] [Related]
6. Altered phosphate metabolism in the intact rabbit lens under high glucose conditions and its prevention by an aldose reductase inhibitor.
González RG; Barnett P; Cheng HM; Chylack LT
Exp Eye Res; 1984 Nov; 39(5):553-62. PubMed ID: 6440802
[TBL] [Abstract][Full Text] [Related]
7. AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats.
Yen TT; Fuller RW; Broderick CL; Hemrick-Luecke SK; Perry KW
Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):257-60. PubMed ID: 3141993
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of aldose reductase inhibitor, antioxidant butylated hydroxytoluene and cysteine protease inhibitor E64 on hyperglycemia-induced metabolic changes in the organ-cultured bovine lens.
Win T; Asano G; Shimizu Y
Nihon Ika Daigaku Zasshi; 1994 Jun; 61(3):180-9. PubMed ID: 8045992
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
10. The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses.
Williams WF; Odom JD
Exp Eye Res; 1987 Jun; 44(6):717-30. PubMed ID: 3115803
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of aldehyde reductase by aldose reductase inhibitors.
Sato S; Kador PF
Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of aldose reductases from rat and bovine lenses by hydantoin derivatives.
Inagaki K; Miwa I; Yashiro T; Okuda J
Chem Pharm Bull (Tokyo); 1982 Sep; 30(9):3244-54. PubMed ID: 6816474
[No Abstract] [Full Text] [Related]
13. Sugar cataracts in vitro: implications of oxidative stress and aldose reductase I.
Chand D; El-Aguizy HK; Richards RD; Varma SD
Exp Eye Res; 1982 Nov; 35(5):491-7. PubMed ID: 6816623
[No Abstract] [Full Text] [Related]
14. [Aldose-reductase inhibitors and cataract formation (author's transl)].
Keller G; Leuenberger PM
Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
[TBL] [Abstract][Full Text] [Related]
15. Spiro hydantoin aldose reductase inhibitors.
Sarges R; Schnur RC; Belletire JL; Peterson MJ
J Med Chem; 1988 Jan; 31(1):230-43. PubMed ID: 3121857
[TBL] [Abstract][Full Text] [Related]
16. Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens.
Yeh LA; Rafford CE; Beyer TA; Hutson NJ
Metabolism; 1986 Apr; 35(4 Suppl 1):4-9. PubMed ID: 3083208
[TBL] [Abstract][Full Text] [Related]
17. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
Cheng HM; González RG
Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
[TBL] [Abstract][Full Text] [Related]
18. [Morphological classification of the prevention by aldose reductase inhibitor of rat galactosemic cataract].
Akagi Y; Ikebe H; Terubayashi H; Takahashi Y; Tsuji T
Nippon Ganka Gakkai Zasshi; 1989 Apr; 93(4):494-500. PubMed ID: 2508449
[TBL] [Abstract][Full Text] [Related]
19. In vitro study of aldose reductase inhibitor concentrations in the lens and inhibitory effect on sugar alcohol accumulation.
Yamamoto Y; Ohtori A
Curr Eye Res; 1990 May; 9(5):421-8. PubMed ID: 2116955
[TBL] [Abstract][Full Text] [Related]
20. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
Ohrloff C; Hockwin O; Korte I; Wegener A
Klin Monbl Augenheilkd; 1986 Nov; 189(5):361-2. PubMed ID: 3100860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
